D-0106-2027 Class II Ongoing

Recalled by Eagle Pharma Outsourcing LLC — Hoover, AL

FDA drug recall D-0106-2027 was initiated by Eagle Pharma Outsourcing LLC on Oct 8, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 5 500-mL containers.

Recall details

Product Type
Drugs
Report Date
Nov 4, 2026
Initiation Date
Oct 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 500-mL containers

Product description

OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide within the U.S

Code information

Lot: OXY30-1006, Expiry: 10/10/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0106-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0106-2027. Report a data issue: hello@regdatalab.com.